Wildcard: Can 10x Genomics 10x?
Industry Focus - A podcast by The Motley Fool
![](https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/b0/03/bb/b003bbdc-ac30-88bf-d429-ea367094a604/mza_1976589887437140566.jpg/300x300bb-75.jpg)
Categories:
In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression. Stocks: 10x Genomics (NASDAQ: TXG) Check out more of our content here: Podcasts Youtube Twitter Reach us by Email @ [email protected]